Here are some stocks for you to consider this week courtesy of the SparkFin app.
A fan favorite, and hugely popular with billionaire hedge fund managers like George Soros and Steve Cohen, Facebook (FB) has recovered from a post-earnings drop. This week could see it hit new all-time highs.
One of the hottest stocks of 2015, Ulta Salon (ULTA) took a hit recently when a negative analyst report was released, but re-captured it’s 200-moving average last week. It will try to keep the momentum up when it announces earnings on Thursday.
After peaking in 2011, gold went into a long-term downtrend. However, last week it showed up on the New 52 Week Highs list, a potential signal that the lows are in — at least for now. The SPDR Gold Trust ETF (GLD) tracks the yellow metal’s price.
After dropping almost 40% since its recent IPO, Square (SQ) — the less famous of the two companies that have a CEO named Jack Dorsey — is clawing its way back up. Good earnings on Wednesday could take it to new highs.
Apple (AAPL) ended 2015 on a sour note, but recent price action has it showing up on our Have These Stocks Bottomed? list. And it might have. Bottomed, that is.
J.C. Penny (JCP) first showed up on the Crossing Above The 200-MA list two weeks ago, and is up 26% since. The stock is a bit overbought in the short-term, but after a rest could continue higher.
Many big winners have come from the Fast Casual Restaurant list, but so far, Shake Shack (SHAK) is not one of them. Dropping 55% from its high, the stock is hovering right below its IPO price. Monday’s earning will tell if the slide is over.
Often, strong stocks will ‘rest’ below their 52-week highs before moving higher. First Solar (FSLR) is one of those stocks, not coincidentally, currently found on our Resting Below 52-Week Highs list.
Oil has been in a relentless downtrend since late 2014, and the United States Oil Fund ETF (USO) has tracked it all the way down. But recent short-term strength in oil may signal a bottom for this ETF, as well as other stocks in the Oil & Gas Patch.
After causing $2B in losses for hedge fund star Bill Ackman, Valeant Pharmaceuticals (VRX) had a dead-cat bounce over the last two weeks. But now it looks like it might be ready to head back lower.
These images are from the SparkFin app which allows you to learn the markets for free, and profit forever. Download it from the App Store now!
